Age-related hearing loss in patients taking cognitive tests may result in misdiagnoses of dementia

 

Leicestershire, UK (July 10, 2020) — The early and correct diagnosis of a cognitive impairment – such as dementia – is crucial as it allows interventions and treatments that may slow the progression of a patient’s symptoms to be quickly put in place.

However, a new study by Loughborough University researcher Dr Christian Füllgrabe further supports that age-related hearing loss can negatively affect the outcome of cognitive tests, resulting in misdiagnoses.

This is because many cognitive screening tests use auditory stimuli (presented orally by a clinician to a patient) for memory recall and people suspected of cognitive decline are typically older, and thus likely to also suffer from age-related hearing loss.
The question of the link between hearing loss and cognitive decline has been hotly debated in recent years, but the answer has been rather elusive.

Dr Füllgrabe’s latest paper further supports that hearing loss can lead to an overestimation of cognitive decline.

In his study, 56 young normal-hearing Loughborough University students with normal cognitive functions were asked to perform three memory tasks using speech stimuli that were either unmodified or modified to mimic age-related hearing loss.

Using participants without hearing impairments allowed Dr Füllgrabe to evaluate the acute effect of hearing loss during the cognitive test on test performance.

Previous studies have used participants with actual hearing impairments but Dr Füllgrabe says as those suffering hearing loss are usually older, it can be hard to determine if the results are due to hearing loss or age-related changes in cognitive processing.

Dr Füllgrabe’s study conclusively demonstrated that memory performance was significantly lower in the group with the simulated hearing loss.

He says the findings are “strong evidence that the presentation format of the cognitive test can impact on the test performance”.

It is hoped the results will raise awareness of the issue and get clinicians to consider the possible impact of age-related hearing loss when interpreting cognitive test results.

Dr Füllgrabe, who works in the School of Sport, Exercise and Health Sciences, commented: “This new publication draws attention to the abusive interpretation that poor performance on a cognitive test necessarily indicates poor cognitive ability.

“As a frequent reviewer for numerous scientific journals and an associate editor of the International Journal of Audiology, I was well placed to witness that this issue was too often ignored.

“As explicitly advocated in the paper, I hope that, in the future, researchers and clinicians alike will consider the hearing status of their participants/patients when administering cognitive tests (such as those used for dementia screening) and interpreting their results.”
Dr Füllgrabe hopes to build on this research with Professor Eef Hogervorst (School of Sport, Exercise and Health Sciences, Loughborough University) and Dr Tobias Bast (Department of Psychology, University of Nottingham).

The researchers are hoping to use the same hearing-loss-simulation approach on a frequently used dementia screening test to help refine dementia diagnostics.

 

 

 


Loughborough University, 10.07.2020 (tB).

Schlagwörter:

MEDICAL NEWS

New guidance to prevent the tragedy of unrecognized esophageal intubation
Overly restrictive salt intake may worsen outcomes for common form…
COVID-19 vaccines are estimated to have prevanented 20 million deaths…
Novel sleep education learning modules developed for nurse practitioners
Scientists discover how salt in tumours could help diagnose and…

SCHMERZ PAINCARE

Aktuelle Versorgungssituation der Opioidtherapie im Fokus
Individuelle Schmerztherapie mit Opioiden: Patienten im Mittelpunkt
Versorgung verbessern: Deutsche Gesellschaft für Schmerzmedizin fordert die Einführung des…
Pflegeexpertise im Fokus: Schmerzmanagement nach Operationen
Versorgung verbessern: Bundesweite Initiative der Deutschen Gesellschaft für Schmerzmedizin zu…

DIABETES

Menschen mit Diabetes während der Corona-Pandemie unterversorgt? Studie zeigt auffällige…
Suliqua® zur Therapieoptimierung bei unzureichender BOT
„Wissen was bei Diabetes zählt: Gesünder unter 7 PLUS“ gibt…
Kaltplasma bei diabetischem Fußsyndrom wirkt via Wachstumsfaktoren
Typ-1-Diabetes: InRange – auf die Zeit im Zielbereich kommt es…

ERNÄHRUNG

Gesunde Ernährung: „Nicht das Salz und nicht das Fett verteufeln“
Mangelernährung gefährdet den Behandlungserfolg — DGEM: Ernährungsscreening sollte zur klinischen…
Wie eine Diät die Darmflora beeinflusst: Krankenhauskeim spielt wichtige Rolle…
DGEM plädiert für Screening und frühzeitige Aufbautherapie: Stationäre COVID-19-Patienten oft…
Führt eine vegane Ernährungsweise zu einer geringeren Knochengesundheit?

ONKOLOGIE

Nahrungsergänzungsmittel während der Krebstherapie: Es braucht mehr Bewusstsein für mögliche…
Fusobakterien und Krebs
Fortgeschrittenes Zervixkarzinom: Pembrolizumab verlängert Leben
Krebspatienten unter Immuntherapie: Kein Hinweis auf erhöhtes Risiko für schwere…
Aktuelle Kongressdaten zum metastasierten Mammakarzinom und kolorektalen Karzinom sowie Neues…

MULTIPLE SKLEROSE

Multiple Sklerose: Analysen aus Münster erhärten Verdacht gegen das Epstein-Barr-Virus
Aktuelle Daten zu Novartis Ofatumumab und Siponimod bestätigen Vorteil des…
Multiple Sklerose durch das Epstein-Barr-Virus – kommt die MS-Impfung?
Neuer Therapieansatz für Multiple Sklerose und Alzheimer
„Ich messe meine Multiple Sklerose selbst!“ – Digitales Selbstmonitoring der…

PARKINSON

Alexa, bekomme ich Parkinson?
Meilenstein in der Parkinson-Frühdiagnose
Parkinson-Erkrankte besonders stark von Covid-19 betroffen
Gangstörungen durch Kleinhirnschädigung beim atypischen Parkinson-Syndrom
Parkinson-Agenda 2030: Die kommenden 10 Jahre sind für die therapeutische…